AUSTIN, Texas–(BUSINESS WIRE)– #MajorContender–SOFTSERVE ACKNOWLEDGED AS A MAJOR CONTENDER IN HEALTHCARE ANALYTICS SERVICES BY EVEREST GROUP
Category: Business
Aerie Concludes Exclusive License Agreement With Santen for Rhopressa® and Rocklatan® in Europe and Several Other Regions
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI, “Aerie”) announced that Aerie and Santen have entered into an exclusive development and commercialization agreement for Rhopressa®/Rhokiinsa® (netarsudil ophthalmic solution) 0.0…
Gyroscope Therapeutics Announces Appointment of Tony Adamis to Board of Directors
LONDON–(BUSINESS WIRE)–Gyroscope Therapeutics announces appointment of Tony Adamis to Board of Directors.
Brazil Electronic Medical Record Markets Report 2021: Licensed Software, Technology Resale, Subscriptions, Professional Services – Forecast to 2026 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Brazil Electronic Medical Record Market – Forecasts from 2021 to 2026” report has been added to ResearchAndMarkets.com’s offering. Brazil Electronic Medical Record market is projected to grow at a CAGR of 8.33% to reach US…
Ocular Therapeutix™ Announces Topline Results for Phase 2 Clinical Trial of OTX-DED for the Short-Term Treatment of Dry Eye Disease
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today a…
Global Wet (Neovascular / Exudative) Macular Degeneration Clinical Trials Market Review, H2 2021 Report – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Wet (Neovascular / Exudative) Macular Degeneration – Global Clinical Trials Review, H2, 2021” clinical trials has been added to ResearchAndMarkets.com’s offering. The report provides an overview of Wet (Neovascular / Exuda…
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEW YORK–(BUSINESS WIRE)–Iveric Bio granted equity-based awards pursuant to the Company’s 2019 Inducement Stock Incentive Plan to six newly-hired, non-executive employees.
Heru Selected to Present Among Titans in Healthcare, Medicine, Science and Business at the 10th Annual Forbes Healthcare Summit
MIAMI–(BUSINESS WIRE)–Mohamed Abou Shousha, MD, PhD, founder and CEO of vision diagnostics and augmentation leader Heru Inc., is among the titans in the industry that have been hand-selected to present virtually this afternoon at the 10th Annual Forb…
Omeros Announces Agreement to Sell OMIDRIA® Franchise to Rayner Surgical in a Transaction Valued in Excess of $1 Billion
SEATTLE–(BUSINESS WIRE)–Omeros Corporation (Nasdaq: OMER) today announced that it has entered into a definitive agreement for the sale of OMIDRIA to Rayner Surgical Group Limited. Expected to close on or before December 31, 2021, the transaction incl…
Global Diabetes Associated Ophthalmic Treatment Market Report 2021-2028: Focus on Dry Eye, Glaucoma, Diabetic Retinopathy, DAMD, Uveitis, Cataract – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Diabetes Associated Ophthalmic Treatment Market 2021-2028” report has been added to ResearchAndMarkets.com’s offering. The global diabetes associated ophthalmic treatment market size is expected to reach USD 44.7 billion b…
Global Central Retinal Vein Occlusion Clinical Trials Market Research Report, H2 2021 Review – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Central Retinal Vein Occlusion – Global Clinical Trials Review, H2, 2021” clinical trials has been added to ResearchAndMarkets.com’s offering. The clinical trial report provides an overview of Central Retinal Vein Occlusio…
Trefoil Therapeutics Announces Third Tranche of $28 Million Series A Financing Based on Achievement of Clinical Trial Objectives
SAN DIEGO–(BUSINESS WIRE)–Trefoil therapeutics announces third tranche of $28 million Series A financing based on achievement of clinical objectives
National Vision Investor Relations Named to Institutional Investor’s 2022 All-America Executive Team
DULUTH, Ga.–(BUSINESS WIRE)– #eyecare–National Vision Holdings, Inc. (NASDAQ: EYE), the nation’s second largest optical retailer, announced that its investor relations leadership have been named to Institutional Investor’s 2022 All-America Executive…
Groupe Vision New Look annonce l'acquisition de Luxury Optical Holdings
MONTRÉAL & NEW YORK–(BUSINESS WIRE)–Groupe Vision New Look annonce aujourd’hui la conclusion d’un accord définitif en vue d’acquérir Luxury Optical Holdings (« LOH » ou la « société »). Avec sa présence existante dans le domaine de l’optique de luxe …
New Look Vision Group Announces the Acquisition of Luxury Optical Holdings
MONTREAL & NEW YORK–(BUSINESS WIRE)–New Look Vision Group announces today that it has entered into a definitive agreement to acquire New York-based Luxury Optical Holdings (“LOH” or the “Company”). With its existing luxury optical presence in Canada,…
GenSight Biologics Announces Publication of Non-Human Primate Study Reporting Presence of LUMEVOQ® Vector DNA in Contralateral Eyes After Unilateral Injection
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…
WALDO Launches Doctor Partnership Program in the United States
NEW YORK–(BUSINESS WIRE)–WALDO, the innovative eyecare brand championing positive vision for all, is pleased to announce the launch of their doctor partnership program in the United States. WALDO is the first direct-to-consumer online contact lens co…
National Vision Holdings, Inc. Increases Share Repurchase Authorization to $100 Million
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) today announced that its Board of Directors has authorized an increase by $50 million to $100 million in the Company’s share repurchase prog…
Kubota Vision Announces Publication in Scientific Reports of Study Data for Wearable Myopia-Control Device
SEATTLE–(BUSINESS WIRE)–Kubota Vision Inc. (Kubota Vision), a clinical-stage specialty ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), today announced the publication of a new paper in the j…
Global Graves' Ophthalmopathy Clinical Trials Market Research Report, H2 2021 Review – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Graves’ Ophthalmopathy – Global Clinical Trials Review, H2, 2021” clinical trials has been added to ResearchAndMarkets.com’s offering. This clinical trial report provides an overview of the Graves’ Ophthalmopathy Clinical …